News
12h
InsideHook on MSNCompounding Controversy Breaks Up Novo Nordisk-Hims & Hers PartnershipAs GLP-1 drugs like Wegovy and Ozempic grow in popularity, so too has a kind of alternative: compounded versions of the drugs ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.
A handful of New York City restaurants have been putting smaller portion sizes on their menus amid the rise of weight-loss ...
In his new book, a former FDA commissioner unpacks the latest science on metabolism, weight loss, and how GLP-1 drugs ...
A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...
Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...
GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...
"These drugs have the potential to change societies, not just individuals." — Michael Le Page, New Scientist, March 29, 2025 ...
All too often celebrities will tell a white lie when asked the secret to their new figure after drastic weight loss, but Amy ...
4d
Flow Space on MSN6 Expert Recommended Steps to Take Before the FDA Cracks Down on GLP-1 DrugsSemaglutide injections are helping you lose weight-but if yours isn't FDA-approved (and a lot of them aren't), it could be ...
Amanda Bynes revealed that she plans to use the injectable drug Ozempic to help achieve her weight loss goals, noting she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results